India's life-sciences patent guidelines promise clarity, but consistency will be the test
India's draft life-sciences patent guidelines could improve predictability without easing patentability standards, but their impact will depend on consistent examination and applying existing jurisprudence to emerging pharmaceutical and biotechnology inventions.India's proposed...To view the full article, register now.
Already a subscriber? Click here to view full article